A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Name: A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Published: 2026
License: Public Domain

J-Pharma Co., Ltd. · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

advanced biliary tract cancer, biliary tract cancer (btc), intrahepatic cholangiocarcinoma (ihc), extrahepatic cholangiocarcinoma (ehc), gallbladder carcinoma (gbc), interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Related documents